Characterization of Unusual Bacteria Isolated from Respiratory Secretions of Cystic Fibrosis Patients and Description of
Inquilinus limosus
gen. nov., sp. nov
-
Published:2002-06
Issue:6
Volume:40
Page:2062-2069
-
ISSN:0095-1137
-
Container-title:Journal of Clinical Microbiology
-
language:en
-
Short-container-title:J Clin Microbiol
Author:
Coenye Tom1, Goris Johan2, Spilker Theodore1, Vandamme Peter2, LiPuma John J.1
Affiliation:
1. Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan 48109 2. Laboratory of Microbiology, Ghent University, Ghent, Belgium
Abstract
ABSTRACT
Using a polyphasic approach (including cellular protein and fatty acid analysis, biochemical characterization, 16S ribosomal DNA sequencing, and DNA-DNA hybridizations), we characterized 51 bacterial isolates recovered from respiratory secretions of cystic fibrosis (CF) patients. Our analyses showed that 24 isolates belong to taxa that have so far not (or only rarely) been reported from CF patients. These taxa include
Acinetobacter
sp.,
Bordetella hinzii
,
Burkholderia fungorum
,
Comamonas testosteroni
,
Chryseobacterium
sp.,
Herbaspirillum
sp.,
Moraxella osloensis
,
Pandoraea
genomospecies 4,
Ralstonia gilardii
,
Ralstonia mannitolilytica
,
Rhizobium radiobacter
, and
Xanthomonas
sp. In addition, one isolate most likely represents a novel
Ralstonia
species, whereas nine isolates belong to novel taxa within the α-
Proteobacteria
. Eight of these latter isolates are classified into the novel genus
Inquilinus
gen. nov. as
Inquilinus limosus
gen. nov., sp. nov., or as
Inquilinus
sp. The remaining 17 isolates are characterized as members of the family
Enterobacteriaceae
. The recovery of these species suggests that the CF lung is an ecological niche capable of supporting the growth of a wide variety of bacteria rarely seen in clinical samples. Elucidation of the factors that account for the association between these unusual species and the respiratory tract of CF patients may provide important insights into the pathophysiology of CF infection. Because accurate identification of these organisms in the clinical microbiology laboratory may be problematic, the present study highlights the utility of reference laboratories capable of identifying unusual species recovered from CF sputum.
Publisher
American Society for Microbiology
Subject
Microbiology (medical)
Reference41 articles.
1. Anzai, Y., H. Kim, J.-Y. Park, H. Wakabayashi, and H. Oyaizu. 2000. Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence. Int. J. Syst. Evol. Microbiol. 50:1563-1589. 2. Baldani, J. I., B. Pot, E. Falsen, V. L. Baldani, F. L. Olivares, B. Hoste, K. Kersters, A. Hartmann, M. Gillis, and J. Dobereiner. 1996. Emended description of Herbaspirillum; inclusion of [Pseudomonas] rubrisubalbicans, a milk plant pathogen, as Herbaspirillum rubrisubalbicans comb. nov.; and classification of a group of clinical isolates (EF group 1) as Herbaspirillum species 3. Int. J. Syst. Bacteriol.46:802-810. 3. Burns, J. L., J. Emerson, J. R. Stapp, D. L. Yim, J. Krzewinski, L. Louden, B. W. Ramsey, and C. R. Clausen. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis.27:158-163. 4. Canton, R., M. I. Morosini, S. Ballestero, M. E. Alvarez, H. Escobar, L. Maiz, and F. Baquero. 1997. Lung colonization with Enterobacteriaceae producing extended-spectrum β-lactamases in cystic fibrosis patients. Pediatr. Pulm.24:213-217. 5. Coenye, T., E. Falsen, B. Hoste, M. Ohlén, J. Goris, J. R. W. Govan, M. Gillis, and, P. Vandamme. 2000. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov., and Pandoraea norimbergensis comb. nov. Int. J. Syst. Evol. Microbiol. 50:887-899.
Cited by
215 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|